Figure 4. Network meta-analysis of 6-months OS and 1-year OS.

Treatments are reported in order of survival rate ranking according to SUCRA of treatment response. Comparisons should be read from left to right. The estimate is located at the intersection of the column-defining treatment and the row-defining treatment. For OS, an OR value above 1 favors the treatment arm. ^*Result with significant difference. Abbreviations: 3DCRT, three—dimension eonformal radiotherapy; DEB-TACE, drug-eluting bead transarterial chemoembolization; HAIC, high-dose hepatic arterial infusion chemotherapy; IFN, interferon-ɑ; PAI, percutaneous acetic acid injection; PEI,percutaneous ethanol injection; PMCT, percutaneous microwave coagulation therapy; RFA, radiofrequency ablation; RT, radiotherapy therapy; SIRT, selective internal radiotherapy; TACE, transarterial chemoembolization; TAI, transarterial infusion chemotherapy.